NO304983B1 - Nye fosfinyloksymetylketoner, farmas°ytisk sammensetning og anvendelse derav - Google Patents
Nye fosfinyloksymetylketoner, farmas°ytisk sammensetning og anvendelse deravInfo
- Publication number
- NO304983B1 NO304983B1 NO942065A NO942065A NO304983B1 NO 304983 B1 NO304983 B1 NO 304983B1 NO 942065 A NO942065 A NO 942065A NO 942065 A NO942065 A NO 942065A NO 304983 B1 NO304983 B1 NO 304983B1
- Authority
- NO
- Norway
- Prior art keywords
- new
- pharmaceutical composition
- phosphinyloxymethyl
- ketones
- phosphinyloxymethyl ketones
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/30—Phosphinic acids R2P(=O)(OH); Thiophosphinic acids, i.e. R2P(=X)(XH) (X = S, Se)
- C07F9/32—Esters thereof
- C07F9/3258—Esters thereof the ester moiety containing a substituent or a structure which is considered as characteristic
- C07F9/3264—Esters with hydroxyalkyl compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
- C07F9/40—Esters thereof
- C07F9/4071—Esters thereof the ester moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4075—Esters with hydroxyalkyl compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/48—Phosphonous acids R—P(OH)2; Thiophosphonous acids including RHP(=O)(OH); Derivatives thereof
- C07F9/4866—Phosphonous acids R—P(OH)2; Thiophosphonous acids including RHP(=O)(OH); Derivatives thereof the ester moiety containing a substituent or structure which is considered as characteristic
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7321993A | 1993-06-04 | 1993-06-04 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO942065D0 NO942065D0 (no) | 1994-06-03 |
| NO942065L NO942065L (no) | 1994-12-05 |
| NO304983B1 true NO304983B1 (no) | 1999-03-15 |
Family
ID=22112457
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO942065A NO304983B1 (no) | 1993-06-04 | 1994-06-03 | Nye fosfinyloksymetylketoner, farmas°ytisk sammensetning og anvendelse derav |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0644197B1 (de) |
| JP (1) | JPH0725887A (de) |
| KR (1) | KR950000717A (de) |
| AT (1) | ATE170868T1 (de) |
| AU (1) | AU685447B2 (de) |
| CA (1) | CA2125080A1 (de) |
| CZ (1) | CZ137994A3 (de) |
| DE (1) | DE69413167T2 (de) |
| DK (1) | DK0644197T3 (de) |
| ES (1) | ES2122145T3 (de) |
| FI (1) | FI942625A (de) |
| IL (1) | IL109901A (de) |
| NO (1) | NO304983B1 (de) |
| NZ (1) | NZ260675A (de) |
| SK (1) | SK68694A3 (de) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6204261B1 (en) | 1995-12-20 | 2001-03-20 | Vertex Pharmaceuticals Incorporated | Inhibitors of interleukin-1β Converting enzyme inhibitors |
| US5874424A (en) * | 1995-12-20 | 1999-02-23 | Vertex Pharmaceuticals Incorporated | Inhibitors of interleukin-1β converting enzyme |
| US6008217A (en) * | 1995-12-20 | 1999-12-28 | Vertex Pharmaceuticals Incorporated | Inhibitors of interleukin-1β converting enzyme |
| US5847135A (en) * | 1994-06-17 | 1998-12-08 | Vertex Pharmaceuticals, Incorporated | Inhibitors of interleukin-1β converting enzyme |
| US5756466A (en) * | 1994-06-17 | 1998-05-26 | Vertex Pharmaceuticals, Inc. | Inhibitors of interleukin-1β converting enzyme |
| US5716929A (en) * | 1994-06-17 | 1998-02-10 | Vertex Pharmaceuticals, Inc. | Inhibitors of interleukin-1β converting enzyme |
| US6420522B1 (en) | 1995-06-05 | 2002-07-16 | Vertex Pharmaceuticals Incorporated | Inhibitors of interleukin-1β converting enzyme |
| AU5122196A (en) * | 1995-03-31 | 1996-10-16 | Takeda Chemical Industries Ltd. | Cysteine protease inhibitor |
| AU6458396A (en) * | 1995-07-17 | 1997-02-18 | Cephalon, Inc. | Phosphorous-containing cysteine and serine protease inhibitors |
| US5639732A (en) * | 1996-07-10 | 1997-06-17 | Cephalon, Inc. | Phosphorous-containing cysteine and serine protease inhibitors |
| EP1389624A1 (de) * | 1995-07-17 | 2004-02-18 | Cephalon, Inc. | Phosphor enthaltende Hemmer von Cystein- und Serin-Proteasen |
| US5843904A (en) * | 1995-12-20 | 1998-12-01 | Vertex Pharmaceuticals, Inc. | Inhibitors of interleukin-1βconverting enzyme |
| GB9702377D0 (en) * | 1996-02-23 | 1997-03-26 | Zeneca Ltd | Peptide derivatives |
| WO1997046578A1 (en) | 1996-06-07 | 1997-12-11 | Zeneca Limited | Peptide derivatives |
| GB9621836D0 (en) * | 1996-10-19 | 1996-12-11 | Zeneca Ltd | Peptide compounds |
| GB9624562D0 (en) | 1996-11-27 | 1997-01-15 | Zeneca Ltd | Peptide derivatives |
| WO1999046248A1 (en) | 1998-03-09 | 1999-09-16 | Vertex Pharmaceuticals Incorporated | 1,2-diazepane derivatives as interleukin-1beta converting enzyme inhibitors |
| KR100898094B1 (ko) | 1998-03-19 | 2009-05-18 | 버텍스 파마슈티칼스 인코포레이티드 | 카스파제의 억제제 |
| US6919437B1 (en) | 1998-06-11 | 2005-07-19 | Isis Pharmaceuticals, Inc. | Synthetic methods and intermediates for triester oligonucleotides |
| US7157430B2 (en) | 1998-10-22 | 2007-01-02 | Idun Pharmaceuticals, Inc. | (Substituted)acyl dipeptidyl inhibitors of the ICE/CED-3 family of cysteine proteases |
| US6242422B1 (en) * | 1998-10-22 | 2001-06-05 | Idun Pharmacueticals, Inc. | (Substituted)Acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases |
| US6525024B1 (en) | 2000-04-17 | 2003-02-25 | Idun Pharmaceuticals, Inc. | Inhibitors of the ICE/ced-3 family of cysteine proteases |
| PE20011350A1 (es) | 2000-05-19 | 2002-01-15 | Vertex Pharma | PROFARMACO DE UN INHIBIDOR DE ENZIMA CONVERTIDORA DE INTERLEUCINA-1ß (ICE) |
| KR100448008B1 (ko) | 2002-07-20 | 2004-09-08 | 주식회사 효성 | 고강도 저수축 폴리에스테르 섬유 및 그 제조방법 |
| GB0411056D0 (en) | 2004-05-18 | 2004-06-23 | Novartis Ag | Organic compounds |
| US7531570B2 (en) | 2004-05-27 | 2009-05-12 | Vertex Pharmaceuticals Incorporated | Treatment of diseases using ICE inhibitors |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE257517T1 (de) * | 1991-08-30 | 2004-01-15 | Vertex Pharma | Interleukin 1-beta protease und ihre inhibitoren |
| GB9123326D0 (en) * | 1991-11-04 | 1991-12-18 | Sandoz Ltd | Improvements in or relating to organic compounds |
-
1994
- 1994-06-02 DK DK94201570T patent/DK0644197T3/da active
- 1994-06-02 AT AT94201570T patent/ATE170868T1/de not_active IP Right Cessation
- 1994-06-02 EP EP94201570A patent/EP0644197B1/de not_active Expired - Lifetime
- 1994-06-02 JP JP6120910A patent/JPH0725887A/ja active Pending
- 1994-06-02 DE DE69413167T patent/DE69413167T2/de not_active Expired - Lifetime
- 1994-06-02 ES ES94201570T patent/ES2122145T3/es not_active Expired - Lifetime
- 1994-06-03 FI FI942625A patent/FI942625A/fi unknown
- 1994-06-03 AU AU64514/94A patent/AU685447B2/en not_active Ceased
- 1994-06-03 NO NO942065A patent/NO304983B1/no not_active IP Right Cessation
- 1994-06-03 NZ NZ260675A patent/NZ260675A/en unknown
- 1994-06-03 CA CA002125080A patent/CA2125080A1/en not_active Abandoned
- 1994-06-03 KR KR1019940012530A patent/KR950000717A/ko not_active Application Discontinuation
- 1994-06-05 IL IL10990194A patent/IL109901A/xx not_active IP Right Cessation
- 1994-06-06 SK SK686-94A patent/SK68694A3/sk unknown
- 1994-06-06 CZ CZ941379A patent/CZ137994A3/cs unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0644197A1 (de) | 1995-03-22 |
| AU685447B2 (en) | 1998-01-22 |
| SK68694A3 (en) | 1995-02-08 |
| KR950000717A (ko) | 1995-01-03 |
| ATE170868T1 (de) | 1998-09-15 |
| FI942625A0 (fi) | 1994-06-03 |
| JPH0725887A (ja) | 1995-01-27 |
| CA2125080A1 (en) | 1994-12-05 |
| NO942065L (no) | 1994-12-05 |
| ES2122145T3 (es) | 1998-12-16 |
| CZ137994A3 (en) | 1995-06-14 |
| DE69413167D1 (de) | 1998-10-15 |
| IL109901A0 (en) | 1994-10-07 |
| NZ260675A (en) | 1996-04-26 |
| FI942625A (fi) | 1994-12-05 |
| IL109901A (en) | 1999-06-20 |
| DK0644197T3 (da) | 1999-06-07 |
| AU6451494A (en) | 1994-12-08 |
| EP0644197B1 (de) | 1998-09-09 |
| NO942065D0 (no) | 1994-06-03 |
| DE69413167T2 (de) | 1999-05-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO304983B1 (no) | Nye fosfinyloksymetylketoner, farmas°ytisk sammensetning og anvendelse derav | |
| NO942064L (no) | yminhibitorer | |
| DK0750618T3 (da) | Oxazolidinonderivater og farmaceutiske præparater indeholdende dem | |
| NO20075066L (no) | Farmasoytisk sammensetning som inneholder isoflavoner | |
| DK0624595T3 (da) | Nor-galdesyrederivater, fremgangsmåde til deres fremstilling og anvendelse af disse forbindelser som lægemidler | |
| NO20006323L (no) | Glykopeptid-derivater og farmasöytiske sammensetninger som inneholder disse | |
| DE68924197T2 (de) | Keine Fäden ziehende, feuchtigkeitshärtende Zusammensetzungen. | |
| DK0530087T3 (da) | Hidtil ukendte naphthylethylurinstof- og naphthylethylthiourinstofforbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem | |
| NL980012I2 (nl) | Mometasonfuroaat-monohydraat, werkwijze om zulks te bereiden en farmaceutische samenstellingen. | |
| DK0579681T3 (da) | Krystallinsk tiagabin-hydrochlorid-monohydrat, dets fremstilling og dets anvendelse | |
| DK166323C (da) | Griseolsyrederivater og farmaceutiske midler indeholdende disse | |
| NO964472L (no) | Halogenmetylamider som IL-1-prosteaseinhibirorer | |
| DK0413668T3 (da) | 2-(RS)-substituerede 2,3-dihydro-5-oxy-4,6,7-trimethylbenzofuraner, der er anvendelige som antioxidant-lægemidler med mucoregulerende og anti-ischæmisk virkning | |
| DK0634396T3 (da) | Aminosyrederivater og deres anvendelse som enkeltfalinaseinhibitorer | |
| FI923751A0 (fi) | Hexahydrobenso/f/kinolinoner. | |
| NO951034L (no) | 10-substituerte 1,8-dihydroksy-9(10H)-antracenonfarmasöytika | |
| NO921491L (no) | Indol- og dihydrokinolinaapnere for kaliumkanal | |
| DK330687A (da) | Forbindelser og farmaceutiske kompositioner, der er anvendelige som cardiotoniske midler | |
| DK630088D0 (da) | Azelastinembonat, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater med indhold af denne forbindelse som aktivt middel | |
| DK0818464T3 (da) | Methylsulfomycin I, fremgangsmåde til dets fremstilling og dets anvendelse | |
| DK1105388T3 (da) | N-substituerede azabicycloheptan-derivater, fremstilling og anvendelse heraf | |
| RU94019328A (ru) | α- ГЕТЕРОАРИЛОКСИМЕТИЛКЕТОНЫ, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, ИНГИБИРУЮЩАЯ ИНТЕРЛЕЙКИН-1 - β -ПРОТЕАЗУ |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |